Skip to content
Screener

MapLight Therapeutics, Inc. MPLT Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$117.66B+22.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$611.36B+67.0%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.22B+19.9%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$4.33B+15.5%
AbbVie logo
AbbVieABBV
$444.6B+35.6%
LBR
LB Pharmaceuticals IncLBRX
$707.12M—

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M—
Total debt$5.6M—
Total equity$399.8M+285%
Total assets$418.8M—

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K—
Free cash flow-$51.2M—

Valuation

See full
Enterprise value$552.07M—

Returns & leverage

See full
Return on equity-216.8%—
Debt / equity0×—
Current ratio22.9×—

Where this comes from

Computed from the period-end share price: $862.73M.

The source filing: MapLight Therapeutics, Inc.’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 4:25 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-224129

FAQ

What is MapLight Therapeutics, Inc.'s market capitalization?
MapLight Therapeutics, Inc. (MPLT) reported market capitalization of $862.73M in Q1 2026.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Ask your AI about MapLight Therapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude